Log In
C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.
Copyright © 2011 American Chemical Society
October 17, 2011 Cover
Volume 89, Issue 42
Volume 89, Issue 42
Faced with change, pharmaceutical firms shift business mix to generics and emerging markets
Credit: Yang H. Ku/C&EN
» Full Article
October 17, 2011 Issue
Volume 89, Issue 42
October 17, 2011 Issue, Vol. 89 | Iss. 42
Faced with change, pharmaceutical firms shift business mix to generics and emerging markets
(pp. 15-20)
Features
Business
Call for drug safety pushes the mundane art of supply chain management to the front burner (pp. 30-32)
Education
New program offers advanced training and first four-year degree in chemical microscopy (pp. 62-63)
Cover Story: Emerging Strategies
Shifting Generics To The Super Side
Some generic drug makers aim to innovate and create differentiated products in a competitive market
(pp. 22-26)News of the Week
Rules For Design
Materials Science: Guidelines predict structures formed by nanoparticles and DNA linkers
(p.9)Congress Passes Trade Agreements
Exports: Pacts will help open markets and create manufacturing jobs, advocates say
(p.10)Identifying Modified Cells
Molecular Biology: Technique tags and enriches cells genetically altered by nucleases
(p.11)Investment Deterrent
Biopharma: Venture capital firms say FDA regulations hamper their support of biopharma companies
(p.11)DOE Demands Solar Patents
Intellectual Property: Bankrupt solar firm developed its manufacturing technology with government grant
(p.12)Linker-Free Molecular Wires
Electronics: Metal-carbon bonds increase electrical conductance
(p.12)Asymmetry From A Guest
Stereochemistry: Enzymelike pocket that hosts chiral species controls catalyst’s enantioselectivity
(p.13)Industry About-Faces On BPA Regulations
Regulation: ACC asks FDA to ban bisphenol A in baby bottles and sippy cups
(p.13)Departments
Business
Call for drug safety pushes the mundane art of supply chain management to the front burner
(pp. 30-32)
Development authorities seek to harness industry‑academia cooperation in the life sciences
(pp. 33-35)
CEO Andrew N. Liveris believes the major pieces are in place to continue the company’s transformation
(pp. 36-38)
Some generic drug makers aim to innovate and create differentiated products in a competitive market
(pp. 22-26)
Faced with change, pharmaceutical firms shift business mix to generics and emerging markets
(pp. 15-20)Concentrates
(pp. 28-29)
(pp. 28-29)- Cleantech Investment Is Up
- PTT Acquires stake in NatureWorks
- Solutia To Buy Southwall
- Firms Form Fluorochemical Pact
- Arkema Debuts Glass Alternative
- Sibur, Sinopec To Collaborate
- Production Resumes At China Solar Plant
- Kuraray Boosts Film for LCDs
- DuPont Starts Up Kevlar Capacity
- Sumitomo Adds To Electronic Materials
- Roche Secures DNA-Sequencing License
- Ligand Licenses Drug To Chiva
- Pfizer Inks Deal With GlycoMimetics
- Business Roundup
ACS News
AstraZeneca and DuPont chemists applauded for breakthroughs
(p.67)
Government & Policy
Import concerns, drug shortages enter into debate on reauthorization of user fees
(pp. 44-46)
U.S. carriers challenge EU law controlling airlines’ greenhouse gas emissions
(pp. 48-50)
Energy Department marks end of fiscal 2011 with key clean energy loan guarantees, grants
(pp. 51-52)Education
New program offers advanced training and first four-year degree in chemical microscopy
(pp. 62-63)
Science & Technology
Yale updates policies on machine shop use after student death
(pp. 56-57)
Conservation scientists seek new ways to keep modern paintings looking their best
(pp. 58-59)
Studies could lead to sensitive and selective analyses for tiny signaling agent
(p.60)Career & Employment
High unemployment forces young European chemists to seek positions in foreign countries
(pp. 71-73)Newscripts
Editor's Page
Letters
Most popular
Viewed
Commented
Chemistry Job Listings